Fig. 3
From: Novel biomanufacturing platform for large-scale and high-quality human T cells production
Robustness and capability of the developed human T cell biomanufacturing. a Comparison of culture volume and container using the re-stimulated CD4+ T cell. b Large-scale culture in 2-L stirred-tank bioreactor using the 1st stimulated CD4+ T cell. c Total cell expansion fold was consistent among various donors. OpTmizer medium was used in the evaluation supplemented with 30 IU/mL IL-2 on Days 0, 2, and 4. *p < 0.05, **p < 0.01. P-values were analyzed by one-way ANOVA. The error bars are presented as SEM